These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 36563698)
21. Lung cancer screening: the radiologist's perspective. Prokop M Semin Respir Crit Care Med; 2014 Feb; 35(1):91-8. PubMed ID: 24481763 [TBL] [Abstract][Full Text] [Related]
22. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer. Baldwin DR; Callister ME Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):672-681. PubMed ID: 27544425 [TBL] [Abstract][Full Text] [Related]
23. The rationale for, and design of, a lung cancer screening program. Mazzone P Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076 [TBL] [Abstract][Full Text] [Related]
24. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer. Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540 [TBL] [Abstract][Full Text] [Related]
25. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Black C; Bagust A; Boland A; Walker S; McLeod C; De Verteuil R; Ayres J; Bain L; Thomas S; Godden D; Waugh N Health Technol Assess; 2006 Jan; 10(3):iii-iv, ix-x, 1-90. PubMed ID: 16409881 [TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of CT screening in the National Lung Screening Trial. Black WC; Gareen IF; Soneji SS; Sicks JD; Keeler EB; Aberle DR; Naeim A; Church TR; Silvestri GA; Gorelick J; Gatsonis C; N Engl J Med; 2014 Nov; 371(19):1793-802. PubMed ID: 25372087 [TBL] [Abstract][Full Text] [Related]
27. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness. Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416 [TBL] [Abstract][Full Text] [Related]
28. Design and Rationale of the HANSE Study: A Holistic German Lung Cancer Screening Trial Using Low-Dose Computed Tomography. Vogel-Claussen J; Lasch F; Bollmann BA; May K; Kuhlmann A; Schmid-Bindert G; Kaaks R; Barkhausen J; Bohnet S; Reck M Rofo; 2022 Dec; 194(12):1333-1345. PubMed ID: 35917826 [TBL] [Abstract][Full Text] [Related]
29. Executive Summary: Screening for Lung Cancer: Chest Guideline and Expert Panel Report. Mazzone PJ; Silvestri GA; Souter LH; Caverly TJ; Kanne JP; Katki HA; Wiener RS; Detterbeck FC Chest; 2021 Nov; 160(5):1959-1980. PubMed ID: 34270965 [TBL] [Abstract][Full Text] [Related]
31. Implementing lung cancer screening: the US experience. Aberle DR Clin Radiol; 2017 May; 72(5):401-406. PubMed ID: 28069160 [TBL] [Abstract][Full Text] [Related]
32. Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps. O'Dowd EL; Baldwin DR Br J Radiol; 2018 Oct; 91(1090):20170460. PubMed ID: 28749712 [TBL] [Abstract][Full Text] [Related]
33. [Lung cancer screening with low dose computed tomography : a systematic review]. Goudemant C; Durieux V; Grigoriu B; Berghmans T Rev Mal Respir; 2021 May; 38(5):489-505. PubMed ID: 33994043 [TBL] [Abstract][Full Text] [Related]
34. Protocol and Rationale for the International Lung Screening Trial. Lim KP; Marshall H; Tammemägi M; Brims F; McWilliams A; Stone E; Manser R; Canfell K; Weber M; Connelly L; Bowman RV; Yang IA; Fogarty P; Mayo J; Yee J; Myers R; Atkar-Khattra S; Lam DCL; Rosell A; Berg CD; Fong KM; Lam S; Ann Am Thorac Soc; 2020 Apr; 17(4):503-512. PubMed ID: 32011914 [No Abstract] [Full Text] [Related]
35. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285 [TBL] [Abstract][Full Text] [Related]
36. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862 [TBL] [Abstract][Full Text] [Related]
37. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. Aberle DR; Abtin F; Brown K J Clin Oncol; 2013 Mar; 31(8):1002-8. PubMed ID: 23401434 [TBL] [Abstract][Full Text] [Related]
38. Computed tomography screening for lung cancer. Sudarshan M; Murthy S Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):660-664. PubMed ID: 32447627 [TBL] [Abstract][Full Text] [Related]
39. Low-dose computed tomography screening reduces lung cancer mortality. Ostrowski M; Marjański T; Rzyman W Adv Med Sci; 2018 Sep; 63(2):230-236. PubMed ID: 29425790 [TBL] [Abstract][Full Text] [Related]
40. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval. Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]